期刊文献+

中药成分联用抑制肝癌细胞增殖及机制研究进展 被引量:4

Research progress on inhibition of hepatoma cells proliferation by combination of traditional Chinese medicine ingredients and its mechanism
原文传递
导出
摘要 肝癌属难治性恶性肿瘤,癌细胞增殖迅速且拥有抵御药物干预的复杂分子应激网络,是其难以治愈的重要原因。发展包含中医药在内的综合治疗手段,开发新药(如中药提取物或有效成分),开展联合用药研究,具有一定的应用前景。通过综述中药成分联用抑制肝癌细胞增殖及机制研究,以期为肝癌的综合治疗及中医药相关研究提供参考。 Hepatoma is a refractory malignant tumor. The rapid proliferation of cancer cells and the complex molecular stress network against drug intervention are the important reasons why it is refractory. It has a certain application prospect to develop comprehensive treatment methods including traditional Chinese medicine,develop new drugs(such as herbal extracts or active ingredients)and carry out research on combined drugs. This paper reviewed the researches on inhibition of proliferation of hepatoma cells by the combination of traditional Chinese medicine and its mechanism,hoping to provide reference for the comprehensive treatment of hepatoma and the related research of traditional Chinese medicine.
作者 吴晓 卢文丽 方肇勤 彭佩克 WU Xiao;LU Wenli;FANG Zhaoqin;PENG Peike(College of Basic Medical Sciences,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处 《上海中医药大学学报》 CAS 2022年第3期97-104,共8页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(82004000,81873212) 上海市进一步加快中医药事业发展三年行动计划项目(ZY[2018-2020]-CCCX-2001-01)。
关键词 肝癌 肝癌细胞 增殖 中药成分 hepatoma hepatoma cell proliferation traditional Chinese medicine ingredients
  • 相关文献

参考文献24

二级参考文献178

共引文献899

同被引文献41

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部